Cargando…
Nose-to-Brain Delivery
Nose-to-brain delivery represents a big challenge. In fact there is a large number of neurological diseases that require therapies in which the drug must reach the brain, avoiding the difficulties due to the blood–brain barrier (BBB) and the problems connected with systemic administration, such as d...
Autores principales: | Giunchedi, Paolo, Gavini, Elisabetta, Bonferoni, Maria Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076467/ https://www.ncbi.nlm.nih.gov/pubmed/32041344 http://dx.doi.org/10.3390/pharmaceutics12020138 |
Ejemplares similares
-
Nanoemulsions for “Nose-to-Brain” Drug Delivery
por: Bonferoni, Maria Cristina, et al.
Publicado: (2019) -
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
por: Bonferoni, Maria Cristina, et al.
Publicado: (2020) -
Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
por: Bonferoni, Maria Cristina, et al.
Publicado: (2020) -
Sericin/crocetin micro/nanoparticles for nucleus pulposus cells regeneration: An “active” drug delivery system
por: Bari, Elia, et al.
Publicado: (2023) -
Indocyanine Green Loaded Polymeric Nanoparticles: Physicochemical Characterization and Interaction Studies with Caco-2 Cell Line by Light and Transmission Electron Microscopy
por: Obinu, Antonella, et al.
Publicado: (2020)